Renewable Energy and Power Inc (RBNW)

[Drugdoctor]

People buy this stock, did-they-read-this-report? lol

https://www.otcmarkets.com/otcapi/company/financial-report/334425/content

Note 5 – Related Party Agreement
The Company has an agreement with its Chief Executive Officer to pay him an annual compensation of $120,000.

Notes Issued in 2019
Livingston Asset Management
On January 1, 2020, the Company issued a $25,000, convertible note payable as advisory fees to Livingston Asset Management (“LAM”). The
note has 10% annual interest, matured on September 30, 2020 and is convertible at 30% of the lowest closing bid price during the 20 days prior
to conversion. The note principal, accrued interest and put premiums balances were $25,000, $7,553 and $10,714 respectively at January 5,
2022, the date of conversion. The note and accrued interest were converted into 517,263,143 shares on the Company’s common stock. The
premium was reclassified to additional paid in capital on the date of conversion.
On February 1, 2020, the Company issued a $25,000, convertible note payable as advisory fees to LAM. The note has 10% annual interest,
matured on October 31, 2020 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion. The note
principal, accrued interest and put premiums balances were $25,000, $7,571 and $10,714 respectively, at February 9, 2022, the date of
conversion. The note and accrued interest were converted into 517,517,571 shares on the Company’s common stock. The premium was
reclassified to additional paid in capital on the date of conversion.
On March 1, 2020, the Company issued a $25,000, convertible note payable as advisory fees to LAM. The note has 10% annual interest,
matured on November 30, 2020 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion. The note
principal, accrued interest and put premiums balances were $25,000, $7,486 and $10,714 respectively, at March 7, 2022, the date of
conversion. The note and accrued interest were converted into 516,304,286 shares on the Company’s common stock. The premium was
reclassified to additional paid in capital on the date of conversion.
The agreement with Livingston Asset Management, LLC was amended effective October 1, 2021 lowering the monthly fee to $15,000. Effective
October 1, 2021 the agreement with LAM was terminated and a new agreement was initiated with Frondeur Partners LLC.

On December 1, 2021, the Company issued a $15,000, convertible note payable as advisory fees to Frondeur Partners LLC. The note has 10%
annual interest, matures on August 31, 2022 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion.
The note principal, accrued interest and put premiums balances were $15,000, 493 and $6,429 respectively, at March 31, 2022.
On January 1, 2022, the Company issued a $15,000, convertible note payable as advisory fees to Frondeur Partners LLC. The note has 10%
annual interest, matures on September 30, 2022 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion.
The note principal, accrued interest and put premiums balances were $15,000, $366 and $6,429 respectively, at March 31, 2022.
On February 1, 2022, the Company issued a $15,000, convertible note payable as advisory fees to Frondeur Partners LLC. The note has 10%
annual interest, matures on October 31, 2022 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion.
The note principal, accrued interest and put premiums balances were $15,000, $238 and $6,429 respectively, at March 31, 2022.
On March 1, 2022, the Company issued a $15,000, convertible note payable as advisory fees to Frondeur Partners LLC. The note has 10%
annual interest, matures on November 30, 2022 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion.
The note principal, accrued interest and put premiums balances were $15,000, $123 and $6,429 respectively, at March 31, 2022.
On December 17 2020, the Company received authorization from the SEC to offer 10,000,000,000 shares of common at price of $0.0002 per
share.
On July 26, 2021, the Company received authorization from the SEC to offer 20,000,000,000 shares of common at price of $0.0002 per share.
Common Stock Issued for Cash Under Reg A Offering
July 26, 2021 Offering:
In the first quarter of 2022, the Company issued 850,000,000 shares of common stock under the terms of the Reg. A offering. The Company
received $170,000 in cash.
(Drugdoctor note... Wanna bet this cash was taken by CEO HUSS for salary? INCREDIBLE!)
Common Stock Issued for Conversion of Debt
From January 1, to March 7, 2022 the Company issued 1,551,085,000 shares of the Company’s common stock to Livingston Asset
Management, LLC in exchange for 3 notes, having principal of $75,000, along with accrued interest of $22,611 and conversion fees of
$10,965. Put premiums of $32,142 were reclassified to additional paid in capital

Note 11 - Subsequent Events
On April 1, 2022, the Company issued a $15,000, convertible note payable as advisory fees to Frondeur Partners LLC. The note has 10%
annual interest, matures on December 31, 2022 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion.
On May 1, 2022, the Company issued a $15,000, convertible note payable as advisory fees to Frondeur Partners LLC. The note has 10% annual
interest, matures on January 31, 2023 and is convertible at 30% of the lowest closing bid price during the 20 days prior to conversion